iCRYO Welcomes Dr. Jason Sonners to Its Medical Advisory Board
In a significant move to bolster its commitment to safe and effective practices in hyperbaric oxygen therapy (HBOT), iCRYO, a prominent name in health and wellness franchising, has announced the appointment of Dr. Jason Sonners, DC, PhD, to its Medical Advisory Board. This strategic addition highlights iCRYO's dedication to providing advanced and accessible health services to its clients.
Dr. Sonners, a noted expert in the field of hyperbaric medicine, brings over 17 years of clinical experience along with a rich academic background that includes a Ph.D. in molecular biology. He is not only a certified hyperbaric practitioner but also the Clinic Director for both NJ HBOT and HBOT USA. His extensive knowledge and hands-on experience are expected to steer iCRYO's HBOT practices toward greater heights, ensuring quality and safety for clients seeking therapeutic solutions.
Known for his written works, including Oxygen Under Pressure and The Art and Science of Hyperbaric Medicine, Dr. Sonners has contributed significantly to the understanding and application of HBOT, particularly regarding its benefits in neurodegenerative conditions, trauma recovery, and comprehensive longevity health. His holistic approach aligns well with iCRYO's mission: to enhance the quality of life for individuals through affordable and professional health services.
Kyle Jones, CEO and Co-founder of iCRYO, expressed enthusiasm over Dr. Sonners' appointment. He noted, "Dr. Sonners' unparalleled expertise and holistic view of wellness will undoubtedly enhance our ability to deliver groundbreaking health solutions within the iCRYO ecosystem. We're focused on ensuring our guests achieve optimal health outcomes, all while prioritizing their safety."
The practice of hyperbaric oxygen therapy, employed by iCRYO, involves clients breathing pressurized ambient air in an enclosed chamber. This method has proven to be effective in promoting tissue repair, reducing inflammation, and accelerating the body's healing processes. As iCRYO continues to offer HBOT with a focus on safety and effectiveness, Dr. Sonners' guidance is anticipated to refine their operational protocols further, integrating evidence-based practices that emphasize individualized care.
"I'm honored to join the Medical Advisory Board at iCRYO and contribute my research and insights to this esteemed team," said Dr. Sonners. "iCRYO is committed to providing a world-class suite of healthcare services that prioritize patient wellness and safety. Together, we aim to make the transformative benefits of hyperbaric oxygen therapy more accessible to a broader demographic."
The inclusion of Dr. Sonners not only elevates the expertise within iCRYO but also serves as a cultivation of advanced therapeutic practices aimed at enhancing health and longevity. This step aligns with the company's broader vision of raising the standard for wellness brands globally.
Founded in 2015, iCRYO continues to expand, incorporating innovative health solutions while maintaining a cost-effective approach for its guests and franchisees. Their commitment remains to elevate the quality of life through improved healthcare accessibility. To explore more about iCRYO's diverse services and franchise opportunities, visit
www.icryo.com.